nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—vertebral column—psoriasis	0.311	0.692	CbGeAlD
Ximelagatran—CYP2C9—Cholecalciferol—psoriasis	0.164	0.479	CbGbCtD
Ximelagatran—F2—endothelium—psoriasis	0.138	0.308	CbGeAlD
Ximelagatran—CYP2C9—Cyclosporine—psoriasis	0.108	0.315	CbGbCtD
Ximelagatran—CYP2C9—Dexamethasone—psoriasis	0.0708	0.207	CbGbCtD
Ximelagatran—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.0222	0.106	CbGpPWpGaD
Ximelagatran—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.0138	0.066	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—ICAM1—psoriasis	0.00804	0.0385	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.00625	0.03	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IFNG—psoriasis	0.00612	0.0293	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINB8—psoriasis	0.00584	0.028	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00572	0.0274	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00565	0.027	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.0052	0.0249	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—NFKB1—psoriasis	0.00509	0.0244	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—CAT—psoriasis	0.0049	0.0235	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—CRP—psoriasis	0.00478	0.0229	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—APOE—psoriasis	0.00468	0.0224	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00464	0.0222	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL4—psoriasis	0.0045	0.0216	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ICAM1—psoriasis	0.0044	0.0211	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL20—psoriasis	0.00402	0.0193	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HCAR2—psoriasis	0.00396	0.0189	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CAT—psoriasis	0.00389	0.0187	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—CRP—psoriasis	0.00389	0.0186	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ICAM1—psoriasis	0.00358	0.0171	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IFNG—psoriasis	0.00335	0.016	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CRP—psoriasis	0.00309	0.0148	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ICAM1—psoriasis	0.00284	0.0136	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.00283	0.0135	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—NFKB1—psoriasis	0.00278	0.0133	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IFNG—psoriasis	0.00272	0.013	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.0027	0.0129	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00263	0.0126	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.00246	0.0118	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.00243	0.0116	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—NFKB1—psoriasis	0.00227	0.0109	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HCAR2—psoriasis	0.00224	0.0107	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.0022	0.0105	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—psoriasis	0.00217	0.0104	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IFNG—psoriasis	0.00216	0.0104	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL20—psoriasis	0.00205	0.00984	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HCAR2—psoriasis	0.00203	0.00972	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00183	0.00877	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—NFKB1—psoriasis	0.0018	0.00862	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—psoriasis	0.00176	0.00844	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—psoriasis	0.00175	0.00837	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ITGAL—psoriasis	0.0017	0.00812	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—psoriasis	0.00155	0.00744	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—REN—psoriasis	0.00152	0.00726	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—psoriasis	0.00142	0.00681	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—psoriasis	0.0014	0.0067	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HCAR2—psoriasis	0.0012	0.00574	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCL20—psoriasis	0.00116	0.00556	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00113	0.00541	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—psoriasis	0.00113	0.00541	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—psoriasis	0.00109	0.0052	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL20—psoriasis	0.00105	0.00505	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TAGAP—psoriasis	0.00104	0.00498	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—psoriasis	0.000946	0.00453	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000782	0.00374	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000729	0.00349	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS2—psoriasis	0.000696	0.00333	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL20—psoriasis	0.000623	0.00298	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—LEP—psoriasis	0.000587	0.00281	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—psoriasis	0.000555	0.00266	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000553	0.00265	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NDUFA5—psoriasis	0.000495	0.00237	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000462	0.00221	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2S1—psoriasis	0.000421	0.00202	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—psoriasis	0.000403	0.00193	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—psoriasis	0.00039	0.00187	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SOCS1—psoriasis	0.000343	0.00164	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TYK2—psoriasis	0.000327	0.00157	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—psoriasis	0.000314	0.0015	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—psoriasis	0.000305	0.00146	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—psoriasis	0.000285	0.00136	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—psoriasis	0.000253	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—psoriasis	0.000253	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKBIA—psoriasis	0.000236	0.00113	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000221	0.00106	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CARM1—psoriasis	0.000206	0.000985	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TYK2—psoriasis	0.000193	0.000925	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000192	0.000921	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—psoriasis	0.000168	0.000806	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—psoriasis	0.00016	0.000766	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUN—psoriasis	0.000156	0.000749	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKB1—psoriasis	0.000151	0.000721	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—psoriasis	0.000137	0.000654	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—psoriasis	0.000135	0.000648	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAT—psoriasis	0.000127	0.000606	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—psoriasis	0.000103	0.000494	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—psoriasis	9.83e-05	0.000471	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—psoriasis	9.45e-05	0.000453	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—psoriasis	8.56e-05	0.00041	CbGpPWpGaD
